CASE REPORT

Salmonella Typhi – a Quiet Bacteria with a Loud Message: an ICU Case Report

Rossi Adu-Gyamfi , Fatima Hoosain, Sean Chetty

Rossi Adu-Gyamfi
1. Department of Surgery Tygerberg Academic Hospital/Stellenbosch University, Cape Town, South Africa 7505; 2. Department of Surgery 37 Military Hospital, Accra Ghana.. Email: drpaoloross@gmail.com

Fatima Hoosain
Department of Surgery Tygerberg Academic Hospital/Stellenbosch University, Cape Town, South Africa 7505;

Sean Chetty
Department of Anaesthesiology and Critical Care, Tygerberg Academic Hospital/Stellenbosch University, Cape Town, South Africa 7505
Online First: August 30, 2019 | Cite this Article
Adu-Gyamfi, R., Hoosain, F., Chetty, S. 2019. Salmonella Typhi – a Quiet Bacteria with a Loud Message: an ICU Case Report. Bali Journal of Anesthesiology 3(2). DOI:10.15562/bjoa.v3i0.161


Typhoid fever, caused by Salmonella enterica, serovar Typhi, is restricted to humans as its host and evades the human immune system with ease. This quality has been one of the many reasons why it is commonly found as an endemic bacterium in emerging economies. Also, due to a remarkably low yield from blood cultures (median of 1 CFU/mL of blood), Salmonella septicemia is uncommon. New evidence gathered together with clinical investigations have provided insight into the mechanisms that underlie the pathogenesis of typhoid, host restriction as well as antibiotic and vaccine susceptibility. However, very little has been done to curb the persistence of disease and emergence of resistant strains. We discuss a case of Salmonella Septic Shock in the Intensive Care Unit (ICU) that takes us through various aspects in diagnosis, the treatment potential and the problems surrounding prevention.

References

Harris JB, Brooks WA. Typhoid and Paratyphoid (Enteric) Fever. In: McGill, A; Ryan, E; Hill, D; Solomon, T, eds. Hunter's Tropical Medicine and Emerging Infectious Diseases. 9th ed. New York: Saunders Elsevier, 2013: 568–576.

Fewtrell L, Colford J. Water, Sanitation and Hygiene: Interventions and Diarrhoea - A Systematic Review and Meta-analysis. Health, Nutrition and Population Discussion Paper. The World Bank. Washington D.C. 2004.

Sabbagh SC, Forest CG, Lepage C, Leclerc JM, Daigle F. So similar, yet so different: uncovering distinctive features in the genomes of Salmonella enterica serovars Typhimurium and Typhi. FEMS Microbiol Lett 2010; 305: 1–13.

Waddington CS, Darton TC, Jones C, Haworth K, Peters A, et al. An outpatient, ambulant design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution. Clin. Infect. Dis 2014; 58:1230–40

Wilson RP, Raffatellu M, Chessa D, Winter SE, Tükel C, Bäumler AJ. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell. Microbiol 2008; 10:876–90

Dougan G, Baker S. Salmonella enterica Serovar Typhi and the Pathogenesis of Typhoid Fever. Annu. Rev. Microbiol 2014; 68:317–36

Gilman RH, Terminel M, Levine MM, Hernandez-Mendoza P, Hornick RB. Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella Typhi in typhoid fever. Lancet 1975; 1(7918):1211–13

Wain J, Diep TS, Ho VA, Walsh AM, Thi N, et al. Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. Microbiology 1998; 36:1683–87

Gopinath S, Carden S, Monack D. Shedding light on Salmonella carriers. Trends Microbiol 2012; 20:320–27

Charles RC, Sultana T, Alam MM, Yu Y, Wu-Freeman Y, et al. Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal. PLoS Negl. Trop. Dis 2013; 7: e2335

Nolan CM, Feeley JC, White PC, Hambie EA, Brown SL, Wong KH. Evaluation of a new assay for Vi antibody in chronic carriers of Salmonella Typhi. J. Clin. Microbiol 1980; 12:22–26

van den Bergh ET, Gasem MH, Keuter M, Dolmans MV. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990. Trop Med Int Health 1999; 4: 211–15

Pfeifer Y, Matten J, Rabsch W. Salmonella enterica serovar Typhi with CTX-M beta-lactamase, Germany. Emerg Infect Dis 2009; 15: 1533–35

Wannemacher RW, DuPont HL, Pekarek RS, Powanda MC, Schwartz A, et al. An endogenous mediator of depression of amino acids and trace metals in serum during typhoid fever. J. Infect. Dis 1972; 126:77–86

Levine MM, Ferreccio C, Cryz S, Ortiz E. Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial. Lancet 1990; 336(8720):891–94


No Supplementary Material available for this article.
Article Views      : 13
PDF Downloads : 7